http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PT-89987-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a899eba0e35112cc25b4aa1b0b7fda90
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
filingDate 1989-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e0f0d96f9b4afd6ccbb65a9da6e49e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25df7ef54bbe046ce43b7b7728778dcc
publicationDate 1989-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PT-89987-A
titleOfInvention METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OSTEOPOROSIS
abstract (A) The use of a 19-unsubstd. progestin for the non-periodic treatment of manifest osteoporosis or for increasing bone mass in a non-periodic treatment of manifest osteoporosis is disclosed. (B) A packing contg. one of the specific 19-unsubstd. progestins allylestrenol, demegestone, ethynodiol diacetate, etc. or a deriv. thereof together with instructions of use in the non-periodic treatment of manifest osteoporosis or increasing bone mass in a non-periodic treatment of manifest osteoporosis is also disclosed.
priorityDate 1988-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491578
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID235905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9270

Total number of triples: 19.